title: Neuronal Fos-like immunoreactivity in ouabain-induced hypertension.
abstract: In normotensive Wistar rats, systemic administration of exogenous ouabain for 10 days or more induces hypertension, presumably through central mechanisms. To identify which neuronal populations may be involved, we assessed Fos-like immunoreactivity (FLI) using an antibody that recognizes the protein products of the fos family comprising Fos, Fos B, Fra 1 and Fra 2, thus enabling detection of chronic neuronal activation. Young Wistar rats received s.c. infusions of either ouabain (50 microg/day) or saline for 7 or 14 days. At the end of the experimental period, mean arterial pressure (MAP) was assessed. In a separate set of rats FLI was detected immunohistochemically and quantified in cardiovascular and osmo-regulating centers. Resting MAP in ouabain-treated rats was significantly higher than in control rats at 14 but not at 7 days (125+/-4 vs. 101+/-6, P<0.05 and 102+/-4 vs. 98+/-6 (not significant), respectively). Within the supraoptic nucleus, ouabain induced significant increases in FLI compared with control rats at 14 days (9+/-2 vs. 2+/-2, P<0.05) but not at 7 days. Within the locus ceruleus, FLI was only detectable in rats that received ouabain infusions for 14 days but not in other groups of rats. Ouabain treatment did not induce significant changes in FLI within other areas. These results demonstrate that chronic s.c. ouabain infusion only increases neuronal FLI in the supraoptic nucleus and locus ceruleus where increases in FLI parallel the increase in blood pressure.
authors.affiliation: Hypertension Unit H360, University of Ottawa Heart Institute and Departments of Cellular and Molecular Medicine, and Medicine, 40 Ruskin Street, University of Ottawa, Ontario K1Y 4W7, Ottawa, Canada.
authors.forename: S J
authors.initials: SJ
authors.lastname: Veerasingham
authors.forename: F
authors.initials: F
authors.lastname: Vahid-Ansari
authors.forename: F H
authors.initials: FH
authors.lastname: Leenen
mesh_terms: D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D006973:Hypertension / Q000139:chemically induced* / Q000378:metabolism* / Q000503:physiopathology; D007150:Immunohistochemistry; D007279:Injections, Subcutaneous; D008125:Locus Coeruleus / Q000378:metabolism; D008297:Male; D009474:Neurons / Q000378:metabolism*; D010042:Ouabain / Q000494:pharmacology; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D012016:Reference Values; D013495:Supraoptic Nucleus / Q000378:metabolism
chemical_list: D016760:Proto-Oncogene Proteins c-fos; D010042:Ouabain